Tg Therapeutics (TGTX) Treasury Shares (2011 - 2026)

Tg Therapeutics' Treasury Shares history runs 15 years deep, the most recent figure standing at $200.2 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 1224.34% year-over-year to $200.2 million; the TTM figure through Mar 2026 stood at $200.2 million (up 1224.34% YoY), while the FY2025 annual figure was $100.2 million, up 1013.71% from the prior year.
• Treasury Shares was $200.2 million for Q1 2026 at Tg Therapeutics, up from $100.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $12.9 million in Q1 2025 to a low of $41309.0 in Q1 2022.
• Historically, Treasury Shares has averaged $4.5 million across 5 years, with a median of $1.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares changed 0.0% in 2022, then surged 9298.29% in 2025.
• A 5-year view of Treasury Shares shows it stood at $234000.0 in 2022, then changed by 0.0% to $234000.0 in 2023, then soared by 3746.15% to $9.0 million in 2024, then surged by 1013.71% to $100.2 million in 2025, then soared by 99.73% to $200.2 million in 2026.
• The last three Treasury Shares figures came in at $200.2 million (Q1 2026), $100.2 million (Q4 2025), and $100.2 million (Q3 2025), per Business Quant data.